Free beta — full access, free until October 2026. No card, no auto-charge — paid plans are opt-in when they launch.
Company
ACCELERON PHARMA INC (0001280600)
Standardized SEC financial data for ACCELERON PHARMA INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001280600 · Biological Products, (No Diagnostic Substances).
Operating margin
-134.5%
Net margin
-128.5%
Revenue growth (YoY)
25.0%
Return on equity
-13.9%
Free cash flow
-$134.5M
Current ratio
14.85×
EPS (diluted)
$-24.84
Ratios for fiscal year 2020, standardized from SEC filings.